Global Oncolytic Virus Therapy Competitive Landscape Professional Research Report 2024

Research Summary

Oncolytic virus therapy, also known as virotherapy, is a type of cancer treatment that utilizes genetically engineered or naturally occurring viruses to selectively target and destroy cancer cells. The viruses used in oncolytic virus therapy are designed to replicate within cancer cells, causing their death while leaving healthy cells unharmed. This therapy takes advantage of the natural ability of certain viruses to infect and replicate within cells. Oncolytic viruses can be modified to enhance their tumor targeting, safety, and anticancer effects. When administered to patients, these viruses selectively infect and replicate within cancer cells, leading to tumor cell lysis and the release of tumor-associated antigens. This process stimulates an immune response, promoting the recognition and destruction of both infected cancer cells and non-infected cancer cells. Oncolytic virus therapy has shown promise in preclinical and clinical trials for various types of cancer and may be used as a standalone treatment or in combination with other cancer therapies, such as chemotherapy, radiation, or immunotherapy. The field of oncolytic virus therapy continues to evolve, with ongoing research and clinical trials aiming to optimize the therapeutic potential and broaden the utility of this innovative treatment approach.

According to DIResearch's in-depth investigation and research, the global Oncolytic Virus Therapy market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Oncolytic Virus Therapy include Amgen, Oncolytics Biotech, Viralytics, Oncolys BioPharma, Transgene SA, Targovax, PsiOxus Therapeutics, SillaJenBiotherapeutics, Genelux Corporation, Sorrento Therapeutics, Lokon Pharma, Cold Genesys, TILT Biotherapeutics, Vyriad etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Oncolytic Virus Therapy. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Oncolytic Virus Therapy market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Oncolytic Virus Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oncolytic Virus Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Oncolytic Virus Therapy Include:

Amgen

Oncolytics Biotech

Viralytics

Oncolys BioPharma

Transgene SA

Targovax

PsiOxus Therapeutics

SillaJenBiotherapeutics

Genelux Corporation

Sorrento Therapeutics

Lokon Pharma

Cold Genesys

TILT Biotherapeutics

Vyriad

Oncolytic Virus Therapy Product Segment Include:

HSV-based Oncolytic Viruses

Adenoviruses-based Oncolytic Viruses

Vaccinia Virus-based Oncolytic Viruses

Vesicular Stomatitis Virus-based Oncolytic Viruses

Newcastle Disease Virus-based Oncolytic Viruses

Oncolytic Virus Therapy Product Application Include:

Melanoma

Prostate Cancer

Breast Cancer

Ovarian Cancer

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Oncolytic Virus Therapy Industry PESTEL Analysis

Chapter 3: Global Oncolytic Virus Therapy Industry Porter's Five Forces Analysis

Chapter 4: Global Oncolytic Virus Therapy Major Regional Market Size and Forecast Analysis

Chapter 5: Global Oncolytic Virus Therapy Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Oncolytic Virus Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Oncolytic Virus Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Oncolytic Virus Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Oncolytic Virus Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Oncolytic Virus Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Oncolytic Virus Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Oncolytic Virus Therapy Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Oncolytic Virus Therapy Market Overview

1.1 Product Definition and Statistical Scope

1.2 Oncolytic Virus Therapy Product by Type

1.2.1 Global Oncolytic Virus Therapy Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 HSV-based Oncolytic Viruses

1.2.3 Adenoviruses-based Oncolytic Viruses

1.2.4 Vaccinia Virus-based Oncolytic Viruses

1.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses

1.2.6 Newcastle Disease Virus-based Oncolytic Viruses

1.3 Oncolytic Virus Therapy Product by Application

1.3.1 Global Oncolytic Virus Therapy Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Melanoma

1.3.3 Prostate Cancer

1.3.4 Breast Cancer

1.3.5 Ovarian Cancer

1.3.6 Others

1.4 Global Oncolytic Virus Therapy Market Revenue Analysis (2019-2030)

1.5 Oncolytic Virus Therapy Market Development Status and Trends

1.5.1 Oncolytic Virus Therapy Industry Development Status Analysis

1.5.2 Oncolytic Virus Therapy Industry Development Trends Analysis

2 Oncolytic Virus Therapy Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Oncolytic Virus Therapy Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Oncolytic Virus Therapy Market Analysis by Regions

4.1 Oncolytic Virus Therapy Overall Market: 2023 VS 2024 VS 2030

4.2 Global Oncolytic Virus Therapy Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Oncolytic Virus Therapy Revenue and Market Share by Region (2019-2024)

4.2.2 Global Oncolytic Virus Therapy Revenue Forecast by Region (2025-2030)

5 Global Oncolytic Virus Therapy Market Size by Type and Application

5.1 Global Oncolytic Virus Therapy Market Size by Type

5.2 Global Oncolytic Virus Therapy Market Size by Application

6 North America

6.1 North America Oncolytic Virus Therapy Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Oncolytic Virus Therapy Market Size by Type

6.4 North America Oncolytic Virus Therapy Market Size by Application

6.5 North America Oncolytic Virus Therapy Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Oncolytic Virus Therapy Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Oncolytic Virus Therapy Market Size by Type

7.4 Europe Oncolytic Virus Therapy Market Size by Application

7.5 Europe Oncolytic Virus Therapy Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Oncolytic Virus Therapy Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Oncolytic Virus Therapy Market Size by Type

8.4 China Oncolytic Virus Therapy Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Oncolytic Virus Therapy Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Oncolytic Virus Therapy Market Size by Type

9.4 APAC (excl. China) Oncolytic Virus Therapy Market Size by Application

9.5 APAC (excl. China) Oncolytic Virus Therapy Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Oncolytic Virus Therapy Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Oncolytic Virus Therapy Market Size by Type

10.4 Latin America Oncolytic Virus Therapy Market Size by Application

10.5 Latin America Oncolytic Virus Therapy Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Oncolytic Virus Therapy Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Type

11.4 Middle East & Africa Oncolytic Virus Therapy Market Size by Application

11.5 Middle East & Africa Oncolytic Virus Therapy Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Oncolytic Virus Therapy Market Revenue by Key Manufacturers (2020-2024)

12.2 Oncolytic Virus Therapy Competitive Landscape Analysis and Market Dynamic

12.2.1 Oncolytic Virus Therapy Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Amgen

13.1.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Amgen Oncolytic Virus Therapy Product Portfolio

13.1.3 Amgen Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Oncolytics Biotech

13.2.1 Oncolytics Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Oncolytics Biotech Oncolytic Virus Therapy Product Portfolio

13.2.3 Oncolytics Biotech Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Viralytics

13.3.1 Viralytics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Viralytics Oncolytic Virus Therapy Product Portfolio

13.3.3 Viralytics Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Oncolys BioPharma

13.4.1 Oncolys BioPharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Oncolys BioPharma Oncolytic Virus Therapy Product Portfolio

13.4.3 Oncolys BioPharma Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Transgene SA

13.5.1 Transgene SA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Transgene SA Oncolytic Virus Therapy Product Portfolio

13.5.3 Transgene SA Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Targovax

13.6.1 Targovax Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Targovax Oncolytic Virus Therapy Product Portfolio

13.6.3 Targovax Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 PsiOxus Therapeutics

13.7.1 PsiOxus Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 PsiOxus Therapeutics Oncolytic Virus Therapy Product Portfolio

13.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 SillaJenBiotherapeutics

13.8.1 SillaJenBiotherapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 SillaJenBiotherapeutics Oncolytic Virus Therapy Product Portfolio

13.8.3 SillaJenBiotherapeutics Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Genelux Corporation

13.9.1 Genelux Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Genelux Corporation Oncolytic Virus Therapy Product Portfolio

13.9.3 Genelux Corporation Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Sorrento Therapeutics

13.10.1 Sorrento Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Sorrento Therapeutics Oncolytic Virus Therapy Product Portfolio

13.10.3 Sorrento Therapeutics Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Lokon Pharma

13.11.1 Lokon Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Lokon Pharma Oncolytic Virus Therapy Product Portfolio

13.11.3 Lokon Pharma Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Cold Genesys

13.12.1 Cold Genesys Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Cold Genesys Oncolytic Virus Therapy Product Portfolio

13.12.3 Cold Genesys Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 TILT Biotherapeutics

13.13.1 TILT Biotherapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 TILT Biotherapeutics Oncolytic Virus Therapy Product Portfolio

13.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 Vyriad

13.14.1 Vyriad Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Vyriad Oncolytic Virus Therapy Product Portfolio

13.14.3 Vyriad Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Oncolytic Virus Therapy Industry Chain Analysis

14.2 Oncolytic Virus Therapy Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Oncolytic Virus Therapy Typical Downstream Customers

14.4 Oncolytic Virus Therapy Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support